Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ACHE | P22303 | 2/20 | 0.41 |
| ▸ | BCHE | P06276 | 1/20 | 0.41 |
| ▸ | HTR2A | P28223 | 1/20 | 0.38 |
| ▸ | CHRM2 | P08172 | 1/20 | 0.33 |
| ▸ | HTR1A | P08908 | 1/20 | 0.33 |
| ▸ | ADRA2A | P08913 | 1/20 | 0.33 |
| ▸ | CHRM1 | P11229 | 1/20 | 0.33 |
| ▸ | DRD1 | P21728 | 1/20 | 0.33 |
| ▸ | SLC6A2 | P23975 | 1/20 | 0.33 |
| ▸ | SLC6A4 | P31645 | 1/20 | 0.33 |
| ▸ | ADRA1A | P35348 | 1/20 | 0.33 |
| ▸ | OPRM1 | P35372 | 1/20 | 0.33 |
| ▸ | DRD3 | P35462 | 1/20 | 0.33 |
| ▸ | SLC6A3 | Q01959 | 1/20 | 0.33 |
| ▸ | HRH3 | Q9Y5N1 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL30638595 | 1.00 | ACHE (0.41) | ACHEBCHEHTR2ACHRM2HTR1A | |
| SCHEMBL812495 | 0.92 | HTR2A (0.39) | ACHEBCHEHTR2ACHRM2HTR1A | |
| SCHEMBL30638592 | 0.92 | HTR2A (0.39) | ACHEBCHEHTR2ACHRM2HTR1A | |
| Hydrochloric Acid SCHEMBL2274495 | 0.80 | ACHE (0.41) | ACHEBCHEHTR2ACHRM2HTR1A | |
| SCHEMBL27619062 | 0.79 | ACHE (0.42) | ACHEBCHEHTR2ACHRM2HTR1A | |
| SCHEMBL313685 | 0.79 | ACHE (0.55) | ACHEBCHEHTR2ACHRM2HTR1A | |
| SCHEMBL2672463 | 0.78 | BCHE (0.41) | ACHEBCHEHTR2A | |
| SCHEMBL2274491 | 0.76 | ACHE (0.40) | ACHEBCHEHTR2ACHRM2HTR1A | |
| Hydrochloric Acid SCHEMBL4307264 | 0.76 | ACHE (0.40) | ACHEBCHEHTR2ACHRM2HTR1A | |
| SCHEMBL28262727 | 0.74 | HTR2A (0.41) | ACHEBCHEHTR2A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 132 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-114901391-B | System and method for producing supported catalysts | 埃克森美孚化学专利公司 | 2024-11-26 | — | — | CN | disclosed |
| US-11618791-B2 | Systems and methods for producing a supported catalyst | EXXONMOBIL CHEMICAL PATENTS INC. (US) | 2023-04-04 | — | — | US | disclosed |
| EP-4065277-A1 | SYSTEMS AND METHODS FOR PRODUCING A SUPPORTED CATALYST | ExxonMobil Chemical Patents Inc. (US) | 2022-10-05 | — | — | EP | disclosed |
| CN-114901391-A | System and method for producing supported catalysts | 埃克森美孚化学专利公司 | 2022-08-12 | — | — | CN | disclosed |
| WO-2021108049-A1 | SYSTEMS AND METHODS FOR PRODUCING A SUPPORTED CATALYST | EXXONMOBIL CHEMICAL PATENTS INC. (US) | 2021-06-03 | — | — | WO | disclosed |
| US-20210155723-A1 | Systems and Methods for Producing a Supported Catalyst | EXXONMOBIL CHEMICAL PATENTS INC (US) | 2021-05-27 | — | — | US | disclosed |
| EP-2872539-B1 | INCREASED POLYMER MELT FLOW RATIO VIA FEED OF A SUPPORTED CATALYST SATURATED WITH A SELECTED LIQUID AGENT | UNIVATION TECH LLC (US) | 2020-12-09 | — | — | EP | disclosed |
| CN-108383935-A | The polymer melt flow ratio for the raising that the supported catalyst being saturated by the liquid reagent of supply selection obtains | 尤尼威蒂恩技术有限责任公司 | 2018-08-10 | — | — | CN | disclosed |
| US-9512254-B2 | Increased polymer melt flow ratio via feed of a supported catalyst saturated with a selected liquid agent | UNIVATION TECHNOLOGIES, LLC (US) | 2016-12-06 | — | — | US | disclosed |
| EP-1716183-B1 | DE-FOAMING SPRAY DRIED CATALYST SLURRIES | UNIVATION TECH LLC (US) | 2016-04-13 | — | — | EP | disclosed |
| WO-2004022230-A1 | PROCESS FOR PRODUCING FLUORINATED CATALYSTS | UNIVATION TECHNOLOGIES, LLC (US) | 2004-03-18 | — | — | WO | disclosed |
| WO-2004022607-A1 | BIMODAL POLYOLEFIN PRODUCTION PROCESS AND FILMS THEREFROM | UNIVATION TECHNOLOGIES, LLC (US) | 2004-03-18 | — | — | WO | disclosed |
| WO-2004022605-A1 | GAS PHASE POLYMERIZATION PROCESS | UNIVATION TECHNOLOGIES, LLC (US) | 2004-03-18 | — | — | WO | disclosed |
| US-20040044153-A1 | Gas phase polymerization process | UNIVATION TECHNOLOGIES, LLC | 2004-03-04 | — | — | US | disclosed |
| US-20040044154-A1 | Bimodal polyolefin production process and films therefrom | UNIVATION TECHNOLOGIES, LLC | 2004-03-04 | — | — | US | disclosed |
| US-20040043893-A1 | Process for producing fluorinated catalysts | UNIVATION TECHNOLOGIES, LLC | 2004-03-04 | — | — | US | disclosed |
| WO-2004003037-A1 | HALOGEN SUBSTITUTED CATALYST SYSTEM FOR OLEFIN POLYMERIZATION | UNIVATION TECHNOLOGIES, LLC. (US) | 2004-01-08 | — | — | WO | disclosed |
| WO-2004003032-A2 | HETEROCYCLIC NITROGEN-CONTAINING ACTIVATORS AND CATALYST SYSTEMS FOR OLEFIN POLYMERIZATION | UNIVATION TECHNOLOGIES, LLC (US) | 2004-01-08 | — | — | WO | disclosed |
| US-20030171514-A1 | Polymerization catalyst activator complexes and their use in a polymerization process | DOW GLOBAL TECHNOLOGIES LLC | 2003-09-11 | — | — | US | disclosed |
| WO-2003064435-A1 | POLYMERIZATION CATALYST ACTIVATOR COMPLEXES AND THEIR USE IN A POLYMERIZATION PROCESS | UNIVATION TECHNOLOGIES, LLC (US) | 2003-08-07 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20040043893-A1 | Process for producing fluorinated catalysts | FLI1, AFF1, INF2 | ACHE 1930/4885BCHE 3850/4885HTR2A 3132/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.